Europe begins review of AstraZeneca COVID drug application

The European Medicines Regulator said it has begun reviewing AstraZeneca’s application for an antibody-based therapy for COVID-19, a key step towards approval of the treatment in the region, but did not provide a timeline for review.

Share this post:

Share on facebook
Share on twitter
Share on pinterest
Share on whatsapp
Related Posts
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore
WordPress Cookie Plugin by Real Cookie Banner